Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Why This Beef Stew Deserves A Spot In Your Weekly Rotation This isn’t your average beef stew—it’s a rich, creamy, ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

Adelle Omondi has been accused of tarnishing the name of Mash Bus Company after she accused them of refusing to give her the ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

Michael Tadros, MD, MPH, discusses how lessons learned from HCV treatment could improve the management of metabolic ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...